Decreased global methylation in patients with bipolar disorder who respond to lithium.

TitleDecreased global methylation in patients with bipolar disorder who respond to lithium.
Publication TypeJournal Article
Year of Publication2014
AuthorsHuzayyin AA, Andreazza AC, Turecki G, Cruceanu C, Rouleau GA, Alda M, L Young T
JournalInt J Neuropsychopharmacol
Date Published2014 Apr
KeywordsAdult, Antipsychotic Agents, Bipolar Disorder, Cells, Cultured, DNA Methylation, Female, Genetic Predisposition to Disease, Humans, Lithium, Lymphocytes, Male, Middle Aged, Oxidative Stress

Mitochondrial dysfunction, oxidative stress, and alterations in DNA methylation, are all associated with the pathophysiology of bipolar disorder (BD). We therefore studied the relationship between oxidative stress and DNA methylation in patients with BD with an excellent response to lithium treatment, their affected and unaffected relatives and healthy controls. Transformed lymphoblasts were cultured in the presence or absence of lithium chloride (0.75 mM). DNA and proteins were extracted from the cells to determine levels of 8-hydroxy-2-deoxyguanosine (8-OHdG), 5-methylcytosine (5-mc), mitochondrial complex I and glutathione peroxidase (GPx) activities. Methylation was decreased in BD subjects and their relatives compared to controls and remained so after lithium treatment in BD subjects but not in their relatives. 8-OHdG levels and complex I activity did not differ between groups before and after lithium treatment. Finally, relatives of patients showed increased GPx activity before and after lithium treatment, which negatively correlated with 5-mc levels. Changes in global methylation may be specific for BD and lithium may be involved in glutathione regulation. The present study supports the importance of DNA methylation to the pathophysiology of BD and the therapeutic potential of antioxidants in this illness.

Alternate JournalInt. J. Neuropsychopharmacol.
PubMed ID24345589
Grant List / / Canadian Institutes of Health Research / Canada